SecBot SecBot
8-K ·Filed Nov 5, 2026

CON

Concentra Group Holdings Parent, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed6d 2h ago SEC0002014596-26-000070
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The combination of a strong Q3 beat, raised full-year guidance, a new $250M buyback authorization, and a credit rating upgrade signals accelerating operational momentum and management confidence. Monitor the Q4 earnings call for updates on the de novo pipeline and M&A execution, as well as any commentary on the new CEO's strategic priorities.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$42.22
T+0 close · Nov 5, 2026 · via day close
Latest settled
+0.43%
T+1 · $42.40
vs SPY
−1.94%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 6 $42.22entry
  2. T+1 · 3d ago +0.43%α −1.94% · $42.40
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 25d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Concentra reported Q3 2026 revenue of $622.1M (+8.6% YoY) and GAAP EPS of $0.52 (+36.8% YoY), beating consensus estimates of $0.44 EPS and $605.4M revenue. The company raised its full-year 2026 revenue guidance to $2.36B-$2.38B and Adjusted EBITDA guidance to $505M-$510M, announced a new $250M share repurchase program, and completed a leadership transition with Matt DiCanio as CEO.

Key Financial Metrics

EPS
$0.52
est $0.44 · +18.2%
Revenue
$622.1M
est $605.4M · +2.8% · +8.6% YoY
Rating
strong beat
Guidance
$2.360B-$2.380B
raised
Free Cash Flow
$32.2M

Key Facts

  • Q3 2026 revenue $622.1M, +8.6% YoY from $572.8M
  • GAAP EPS $0.52, +36.8% YoY from $0.38
  • Adjusted EBITDA $140.2M, +17.9% YoY, margin expanded 178bps to 22.5%
  • Net income $67.8M, +36.0% YoY; net income margin expanded 220bps to 10.9%
  • Patient visits +4.9% YoY to 58,312 per day; revenue per visit +3.3% to $152.14
  • Raised FY 2026 revenue guidance to $2.36B-$2.38B (from $2.325B-$2.375B)
  • Raised FY 2026 Adjusted EBITDA guidance to $505M-$510M (from $485M-$495M)
  • Board authorized new $250M share repurchase program with no expiration
  • Net leverage ratio improved to 2.90x; S&P upgraded credit rating from BB- to BB
  • CEO transition completed: Matt DiCanio succeeded Keith Newton as CEO effective Nov 1

Financial Impact

Q3 revenue beat consensus by $16.7M (2.8%); GAAP EPS beat consensus by $0.08 (18.2%); FY guidance raised for both revenue and EBITDA

revenueepsadjusted_ebitdanet_incomepatient_visitsrevenue_per_visitnet_leverage

Segment Breakdown

SegmentRevenueGrowth
Occupational health centers - Workers compensation$370.5M+7.9%
Occupational health centers - Employer services$190.5M+10.0%
Occupational health centers - Consumer health$6.7M-9.0%
Occupational health centers - Other$1.9M-3.6%
Onsite health clinics$38.4M+10.0%
Other$14.1M+18.4%

Risk Factors

  • Consumer health visits declined 6.7% YoY, a small but persistent negative trend
  • Free cash flow in Q3 was $32.2M vs $40.2M in Q3 2025, down 19.9% due to higher capex and working capital
  • Transition services agreement with Select Medical expires in November 2026, introducing potential operational complexity

Market Snapshot

Exchange
NYSE
Sector
Services-Specialty Outpatient Facilities, NEC
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0002014596-26-000070
Document: cghp-20261104.htm0002014596-26-000070
Document: concentrainvestorpresent.htm0002014596-26-000070
Document: 0002014596-26-000070-index-headers.html0002014596-26-000070
Document: 0002014596-26-000070-index.html0002014596-26-000070
Document: 0002014596-26-000070.txt0002014596-26-000070
8-K Data (Synthetic)0002014596-26-000070

Track record

13 reports on CON

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +8.49% at T+1 after the Nov 3, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 10, 20261d ago SC 13D/A Neutral 4/10 Entry $42.40 Now $43.45 +2.48% settles Nov 12
  2. Nov 10, 20261d ago 8-K Neutral 3/10 Entry $42.40 Now $43.45 +2.48% settles Nov 12
  3. Nov 9, 20262d ago 8-K Neutral 2/10 Entry $42.67 to $43.45 Now $43.45 +1.83% ▲ +1.83% +0.51% vs SPY
  4. Nov 5, 20266d ago 3 Neutral 2/10 Entry $42.22 to $42.40 Now $43.45 +2.91% ▲ +0.43% −1.94% vs SPY
  5. Nov 5, 20266d ago 8-K Bullish 6/10 Viewing Entry $42.22 to $42.40 Now $43.45 +2.91% ▲ +0.43% −1.94% vs SPY
  6. Nov 3, 20268d ago Institutional Cluster Bullish 4/10 Entry $40.15 to $43.56 Now $43.45 +8.22% ▲ +8.49% +6.84% vs SPY
  7. Jun 30, 202619w ago 144 Neutral 2/10 Entry $30.77 to $31.91 Now $43.45 +41.21% ▲ +3.70% +3.84% vs SPY
  8. Jun 29, 202619w ago 144 Neutral 2/10 Entry $29.75 to $30.77 Now $43.45 +46.05% ▲ +3.43% +3.56% vs SPY
  9. Jun 26, 202619w ago 144 Neutral 3/10 Entry $29.77 to $29.75 Now $43.45 +45.95% ▼ −0.07% −0.85% vs SPY
  10. Jun 1, 202623w ago 144 Bearish 5/10 Entry $25.09 to $24.75 Now $43.45 −73.18% ▲ +1.36% +0.63% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens Fri (14h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026